TherapeuticsMD (TXMD) Other Non-Current Assets (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Other Non-Current Assets came in at $419000.0 in Q1 2026, up 98.58% YoY from $211000.0 in Q1 2025, and down 5.63% on a QoQ basis from $444000.0 in Q4 2025.
TherapeuticsMD (TXMD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Other Non-Current Assets data on file, last reported at $419000.0 in Q1 2026.
- Quarterly Other Non-Current Assets rose 98.58% year-over-year to $419000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $419000.0 (up 98.58% YoY) and the FY2025 annual result came in at $444000.0, up 241.54% from the prior year.
- Other Non-Current Assets declined to $419000.0 in Q1 2026, from $444000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $470000.0 in Q3 2025 to a low of $58000.0 in Q1 2024.
- A 5-year average of $258470.6 and a median of $253000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets tumbled 99.25% — and 2025, when it surged 710.34%.
- Tracing TXMD's Other Non-Current Assets over 5 years: stood at $253000.0 in 2022, then jumped by 35.97% to $344000.0 in 2023, then sank by 62.21% to $130000.0 in 2024, then soared by 241.54% to $444000.0 in 2025, then retreated by 5.63% to $419000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $419000.0 (Q1 2026), $444000.0 (Q4 2025), and $470000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 395,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 395,000.00 |
| Mar 31, 2026 | 419,000.00 |
| Dec 31, 2025 | 444,000.00 |
| Sep 30, 2025 | 470,000.00 |
| Jun 30, 2025 | 428,000.00 |
| Mar 31, 2025 | 211,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 58,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 344,000.00 |
| Sep 30, 2023 | 254,000.00 |
| Jun 30, 2023 | 254,000.00 |
| Mar 31, 2023 | 253,000.00 |
| Dec 31, 2022 | 253,000.00 |
| Sep 30, 2022 | 253,000.00 |
| Jun 30, 2022 | 254,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Dec 31, 2021 | 33.55 Mn |
| Sep 30, 2021 | 253,000.00 |